Prognosis and Survival Rates
Written by: Sarah O'Brien | Last reviewed: April 2019.
- National Cancer Institute. Dictionary of Cancer Terms. Accessed February 21, 2017 at: https://www.cancer.gov/publications/dictionaries/cancer-terms.
- American Cancer Society. Melanoma skin cancer. Accessed January 5, 2017 at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003120-pdf.pdf
- Mun GH. Management of malignant melanoma. Arch Plast Surg. 2012 Sep;39(5):565-74.
- Shenenberger DW. Cutaneous malignant melanoma: a primary care perspective. Am Fam Physician. 2012;85:161-168.
- SEER Cancer Stat Facts: Melanoma of the Skin. National Cancer Institute. Bethesda, MD. Accessed April 26, 2019 at: http://seer.cancer.gov/statfacts/html/melan.html
- Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Melanoma of the Skin (Invasive); Table 16.7. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
- Rudin C. Molecular Profiling of Basal Cell Carcinoma (Updated July 15, 2015). My Cancer Genome. Accessed January 6, 2017 at: https://www.mycancergenome.org/content/disease/basal-cell-carcinoma/.
- American Cancer Society. Basal and squamous cell skin cancers. Accessed January 5, 2017 at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003139-pdf.pdf
- Firnhaber JM. Diagnosis and treatment of basal cell and squamous cell carcinoma. Am Fam Physician. 2012;86:161-168.
- NCCN Clinical Practice Guidelines in Oncology. Basal cell skin cancer. Version 1.2017. Published October 3, 2016. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf
- McCusker M, Basset-Seguin N, Dummer R, et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer. 2014;50:774-783.
- Lewis KD, Sekulic A, Hauschild A, et al. Vismodegib in the treatment of patients with metastatic basal cell carcinoma (mBCC) and distant metastases: Survival in the pivotal phase II and phase I studies. Abstract 9012. Presented at 2014 ASCO Annual Meeting.
- Dummer R, Migden MR, Guminski A, et al. Efficacy and safety of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BCC): BOLT 30-month analysis. Abstract 9538. Presented at 2016 ASCO Annual Meeting.
- NCCN Clinical Practice Guidelines in Oncology. Squamous cell skin cancer. Version 1.2017. Published October 3, 2016. https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf
- Harwood CA, Proby CM, Inman GJ, Leigh IM. The promise of genomics and the development of targeted therapies for cutaneous squamous cell carcinoma. Acta Derm Venereol. 2016;96:3-16.
- Burton KA, Ashack KA, Khachemoune A. Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease. Am J Clin Dermatol. 2016;17:491-508.